US Patent Issued to REMIX THERAPEUTICS on Oct. 27 for "Heterocyclic amides and their use for modulating splicing" (Massachusetts Inventors)

ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,774,281, issued on Oct. 27, was assigned to REMIX THERAPEUTICS INC. (Watertown, Mass.).

"Heterocyclic amides and their use for modulating splicing" was invented by Dominic Reynolds (Stoneham, Mass.), Michael W. Seiler (Belmont, Mass.), Anant A. Agrawal (Waltham, Mass.), Frederic Vaillancourt (Newton, Mass.) and Peter Smith (Arlington, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure features compounds of formula (I-a) and related compositions that, inter alia, modulate nucleic acid splicing e.g., splicing of a pre-mRNA, as well as methods of use thereof."

The patent was filed on Feb. 28, 2021, under Application No. 17/802,719...